Daiwa Securities Group Inc. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3
-25.0%
2720.0%0.00%
Q2 2023$40.0%2720.0%0.00%
Q1 2023$40.0%2720.0%0.00%
Q4 2022$4
-99.9%
272
+36.7%
0.00%
Q3 2022$4,000
+33.3%
1990.0%0.00%
Q2 2022$3,000
+50.0%
1990.0%0.00%
Q1 2022$2,0000.0%1990.0%0.00%
Q4 2021$2,000
-71.4%
1990.0%0.00%
Q3 2021$7,000
+75.0%
199
+86.0%
0.00%
Q2 2021$4,000
-20.0%
1070.0%0.00%
Q1 2021$5,000
-16.7%
1070.0%0.00%
Q4 2020$6,000
-62.5%
107
-66.4%
0.00%
Q3 2020$16,000
+33.3%
318
+5.3%
0.00%
Q2 2020$12,0000.0%3020.0%0.00%
Q1 2020$12,000
-33.3%
302
+4.9%
0.00%
Q4 2019$18,000
+63.6%
288
-7.7%
0.00%
Q3 2019$11,000
+120.0%
312
+30.0%
0.00%
Q2 2019$5,000
-16.7%
2400.0%0.00%
Q1 2019$6,000
-14.3%
240
-27.3%
0.00%
Q4 2018$7,0003300.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders